BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 31847897)

  • 1. Nanotechnology in cancer diagnosis: progress, challenges and opportunities.
    Zhang Y; Li M; Gao X; Chen Y; Liu T
    J Hematol Oncol; 2019 Dec; 12(1):137. PubMed ID: 31847897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology enabling the use of circulating tumor cells (CTCs) as reliable cancer biomarkers.
    Hong S; Wang AZ
    Adv Drug Deliv Rev; 2018 Feb; 125():1-2. PubMed ID: 29880212
    [No Abstract]   [Full Text] [Related]  

  • 3. Nanotechnology in Radiation Oncology.
    Sun B; Hagan CT; Caster J; Wang AZ
    Hematol Oncol Clin North Am; 2019 Dec; 33(6):1071-1093. PubMed ID: 31668207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted nanotechnology for cancer imaging.
    Toy R; Bauer L; Hoimes C; Ghaghada KB; Karathanasis E
    Adv Drug Deliv Rev; 2014 Sep; 76():79-97. PubMed ID: 25116445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of biomimicry and nanotechnology for significantly improved detection of circulating tumor cells (CTCs).
    Myung JH; Park SJ; Wang AZ; Hong S
    Adv Drug Deliv Rev; 2018 Feb; 125():36-47. PubMed ID: 29247765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology for cancer diagnostics: promises and challenges.
    Grodzinski P; Silver M; Molnar LK
    Expert Rev Mol Diagn; 2006 May; 6(3):307-18. PubMed ID: 16706735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology for early cancer detection.
    Choi YE; Kwak JW; Park JW
    Sensors (Basel); 2010; 10(1):428-55. PubMed ID: 22315549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology: A Promising Approach for Cancer Diagnosis, Therapeutics and Theragnosis.
    Dessale M; Mengistu G; Mengist HM
    Int J Nanomedicine; 2022; 17():3735-3749. PubMed ID: 36051353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What can nanotechnology do to fight cancer?
    Gallego O; Puntes V
    Clin Transl Oncol; 2006 Nov; 8(11):788-95. PubMed ID: 17134966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology Strategies for the Analysis of Circulating Tumor DNA: A Review.
    Chen X; Wang L; Lou J
    Med Sci Monit; 2020 Mar; 26():e921040. PubMed ID: 32200389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantum dots and multifunctional nanoparticles: new contrast agents for tumor imaging.
    Rhyner MN; Smith AM; Gao X; Mao H; Yang L; Nie S
    Nanomedicine (Lond); 2006 Aug; 1(2):209-17. PubMed ID: 17716110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoplasmonic sensors for detecting circulating cancer biomarkers.
    Ferhan AR; Jackman JA; Park JH; Cho NJ; Kim DH
    Adv Drug Deliv Rev; 2018 Feb; 125():48-77. PubMed ID: 29247763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnology for sensing, imaging, and treating cancer.
    Panchapakesan B; Wickstrom E
    Surg Oncol Clin N Am; 2007 Apr; 16(2):293-305. PubMed ID: 17560513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Nanotechnology in Medicine: A Promising Approach for Cancer Detection and Diagnosis.
    Stephen BJ; Suchanti S; Mishra R; Singh A
    Crit Rev Ther Drug Carrier Syst; 2020; 37(4):375-405. PubMed ID: 32865930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in nanotechnology-based detection and separation of circulating tumor cells.
    Myung JH; Tam KA; Park SJ; Cha A; Hong S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(2):223-39. PubMed ID: 26296639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment.
    Phan JH; Moffitt RA; Stokes TH; Liu J; Young AN; Nie S; Wang MD
    Trends Biotechnol; 2009 Jun; 27(6):350-8. PubMed ID: 19409634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the DNA Nanotechnology for the Cancer Biomarkers Analysis: Attributes and Applications.
    Xia LY; Tang YN; Zhang J; Dong TY; Zhou RX
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):1105-1119. PubMed ID: 34979273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of non-EpCAM based circulating tumor cell assays.
    Austin RG; Huang TJ; Wu M; Armstrong AJ; Zhang T
    Adv Drug Deliv Rev; 2018 Feb; 125():132-142. PubMed ID: 29366804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilising extracellular vesicles for early cancer diagnostics: benefits, challenges and recommendations for the future.
    Pink RC; Beaman EM; Samuel P; Brooks SA; Carter DRF
    Br J Cancer; 2022 Feb; 126(3):323-330. PubMed ID: 35013578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in point-of-care diagnostic devices in cancers.
    Sandbhor Gaikwad P; Banerjee R
    Analyst; 2018 Mar; 143(6):1326-1348. PubMed ID: 29469148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.